142 related articles for article (PubMed ID: 11950701)
1. Cerivastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase, inhibits endothelial cell proliferation induced by angiogenic factors in vitro and angiogenesis in in vivo models.
Vincent L; Soria C; Mirshahi F; Opolon P; Mishal Z; Vannier JP; Soria J; Hong L
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):623-9. PubMed ID: 11950701
[TBL] [Abstract][Full Text] [Related]
2. Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study.
Denoyelle C; Vasse M; Körner M; Mishal Z; Ganné F; Vannier JP; Soria J; Soria C
Carcinogenesis; 2001 Aug; 22(8):1139-48. PubMed ID: 11470741
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect.
Vincent L; Chen W; Hong L; Mirshahi F; Mishal Z; Mirshahi-Khorassani T; Vannier JP; Soria J; Soria C
FEBS Lett; 2001 Apr; 495(3):159-66. PubMed ID: 11334884
[TBL] [Abstract][Full Text] [Related]
4. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (pravastatin) inhibits endothelial cell proliferation dependent on G1 cell cycle arrest.
Asakage M; Tsuno NH; Kitayama J; Kawai K; Okaji Y; Yazawa K; Kaisaki S; Takahashi K; Nagawa H
Anticancer Drugs; 2004 Jul; 15(6):625-32. PubMed ID: 15205608
[TBL] [Abstract][Full Text] [Related]
5. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.
Park HJ; Kong D; Iruela-Arispe L; Begley U; Tang D; Galper JB
Circ Res; 2002 Jul; 91(2):143-50. PubMed ID: 12142347
[TBL] [Abstract][Full Text] [Related]
6. Statins have biphasic effects on angiogenesis.
Weis M; Heeschen C; Glassford AJ; Cooke JP
Circulation; 2002 Feb; 105(6):739-45. PubMed ID: 11839631
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells.
Denoyelle C; Albanese P; Uzan G; Hong L; Vannier JP; Soria J; Soria C
Cell Signal; 2003 Mar; 15(3):327-38. PubMed ID: 12531431
[TBL] [Abstract][Full Text] [Related]
8. Cerivastatin, a HMG-CoA reductase inhibitor, reduces plasminogen activator inhibitor-1 (PAI-1) expression in endothelial cells by down-regulation of cellular signaling and the inhibition of PAI-1 promoter activity.
Swiatkowska M; Pawlowska Z; Szemraj J; Drzewoski J; Watala C; Cierniewski CS
Jpn J Pharmacol; 2002 Dec; 90(4):337-44. PubMed ID: 12501010
[TBL] [Abstract][Full Text] [Related]
9. Insights in the molecular mechanisms of the anti-angiogenic effect of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Vincent L; Albanese P; Bompais H; Uzan G; Vannier JP; Steg PG; Soria J; Soria C
Thromb Haemost; 2003 Mar; 89(3):530-7. PubMed ID: 12624638
[TBL] [Abstract][Full Text] [Related]
10. HMG-CoA reductase inhibitors suppress intracellular calcium mobilization and membrane current induced by lysophosphatidylcholine in endothelial cells.
Yokoyama K; Ishibashi T; Ohkawara H; Kimura J; Matsuoka I; Sakamoto T; Nagata K; Sugimoto K; Sakurada S; Maruyama Y
Circulation; 2002 Feb; 105(8):962-7. PubMed ID: 11864926
[TBL] [Abstract][Full Text] [Related]
11. HMG-CoA reductase inhibitor simvastatin overcomes bortezomib-induced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway.
Fuchs D; Berges C; Opelz G; Daniel V; Naujokat C
Biochem Biophys Res Commun; 2008 Sep; 374(2):309-14. PubMed ID: 18625202
[TBL] [Abstract][Full Text] [Related]
12. Cerivastatin-induced apoptosis of human aortic smooth muscle cells through partial inhibition of basal activation of extracellular signal-regulated kinases.
Takata R; Fukasawa S; Hara T; Nakajima H; Yamashina A; Yanase N; Mizuguchi J
Cardiovasc Pathol; 2004; 13(1):41-8. PubMed ID: 14761784
[TBL] [Abstract][Full Text] [Related]
13. Cerivastatin potentiates nitric oxide release and enos expression through inhibition of isoprenoids synthesis.
Kalinowski L; Dobrucki IT; Malinski T
J Physiol Pharmacol; 2002 Dec; 53(4 Pt 1):585-95. PubMed ID: 12512694
[TBL] [Abstract][Full Text] [Related]
14. Statins suppress oxidized low density lipoprotein-induced macrophage proliferation by inactivation of the small G protein-p38 MAPK pathway.
Senokuchi T; Matsumura T; Sakai M; Yano M; Taguchi T; Matsuo T; Sonoda K; Kukidome D; Imoto K; Nishikawa T; Kim-Mitsuyama S; Takuwa Y; Araki E
J Biol Chem; 2005 Feb; 280(8):6627-33. PubMed ID: 15611087
[TBL] [Abstract][Full Text] [Related]
15. Geranylgeranylpyrophosphate plays a key role for the G1 to S transition in vascular smooth muscle cells.
Terano T; Shiina T; Noguchi Y; Tanaka T; Tatsuno I; Saito Y; Yasuda T; Kitagawa M; Hirai A
J Atheroscler Thromb; 1998; 5(1):1-6. PubMed ID: 10077451
[TBL] [Abstract][Full Text] [Related]
16. Cerivastatin, a hydroxymethylglutaryl coenzyme A reductase inhibitor, inhibits cardiac myocyte hypertrophy induced by endothelin.
Nishikimi T; Tadokoro K; Wang X; Mori Y; Asakawa H; Akimoto K; Yoshihara F; Horio T; Minamino N; Matsuoka H
Eur J Pharmacol; 2002 Oct; 453(2-3):175-81. PubMed ID: 12398901
[TBL] [Abstract][Full Text] [Related]
17. Statins inhibit in vitro calcification of human vascular smooth muscle cells induced by inflammatory mediators.
Kizu A; Shioi A; Jono S; Koyama H; Okuno Y; Nishizawa Y
J Cell Biochem; 2004 Nov; 93(5):1011-9. PubMed ID: 15389884
[TBL] [Abstract][Full Text] [Related]
18. HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins.
Yang Z; Kozai T; van der Loo B; Viswambharan H; Lachat M; Turina MI; Malinski T; Lüscher TF
J Am Coll Cardiol; 2000 Nov; 36(5):1691-7. PubMed ID: 11079678
[TBL] [Abstract][Full Text] [Related]
19. Hmg-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro: involvement of Rho GTPase-dependent mechanism.
Yoshida M; Sawada T; Ishii H; Gerszten RE; Rosenzweig A; Gimbrone MA; Yasukochi Y; Numano F
Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1165-71. PubMed ID: 11451746
[TBL] [Abstract][Full Text] [Related]
20. Contribution of Rho A and Rho kinase to platelet-derived growth factor-BB-induced proliferation of vascular smooth muscle cells.
Kamiyama M; Utsunomiya K; Taniguchi K; Yokota T; Kurata H; Tajima N; Kondo K
J Atheroscler Thromb; 2003; 10(2):117-23. PubMed ID: 12740486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
